StarTribune.com
stem092908.box

Home | Business

TOWARD THE GOAL LINE

Last update: September 28, 2008 - 10:47 PM

Getting stem-cell products to market has been agonizingly slow, but some companies are getting close.

OSIRIS THERAPEUTICS INC.

Headquarters: Columbia, Md.

Business: The company is conducting a Phase III clinical trial of a stem-cell therapy used to treat graft vs. host disease, in which the immune cells from a transplanted bone marrow attack the cells of the recipient.

ATHERSYS INC.

Headquarters: Cleveland

Business: The start-up is developing stem-cell therapies to treat cardiovascular and neurological diseases and cancer.

ALDAGEN INC.

Headquarters: Durham, N.C.

Business: The company just started a Phase III clinical trial of a stem-cell treatment to improve umbilical cord blood transplants for kids with inherited metabolic diseases.

Recent Business stories

Adam Lambert's awards show performance draws a 'moderate' number of complaints for ABC - September 28, 2008
Adam Lambert's awards show performance draws a 'moderate' number of complaints for ABC - Complaints poured in Monday about Adam Lambert's sexually charged performance at the American Music Awards, including criticism of his kiss with a male keyboard player that was left out of rehearsals for the show. More

Comment on this story   |   Be the first to comment   |  Hide reader comments

Subscribe

Blog: Patent Pending

Lights out at U energy conference. Irony police notified.

Just as Lawrence Kazmerski, a top official at the National Renewable Energy Laboratory, was about to give the keynote address at the University of Minnesota's annual E3 conference at the RiverCentre in St. Paul, the lights went out, bathing the audience in darkness and a deep sense of irony.

Recent posts